Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,264 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

NCT04802759

Conditions
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Santa Monica, California, United States
View all 32 locations
View Trial Details
Recruiting

Asciminib Roll-over Study

NCT04877522

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
Locations
  • Michigan Med University of Michigan Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University Portland, Oregon, United States
  • Texas Oncology Dallas, Texas, United States
View all 85 locations
View Trial Details
Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT07483658

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Digestive System Diseases, Female Urogenital Diseases, +22 more
Locations
  • Gatineau Hospital Gatineau, Quebec, Canada
  • Hôpital Général Juif Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
  • CHU de Québec-Université Laval Québec, Quebec, Canada
View Trial Details
Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

NCT07129252

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +13 more
Locations
  • Crinetics Study Site Phoenix, Arizona, United States
  • Crinetics Study Site Duarte, California, United States
  • Crinetics Study Site Newport Beach, California, United States
  • Crinetics Study Site Orange, California, United States
View all 26 locations
View Trial Details
Recruiting

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07450859

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Siteman Cancer Center (Washington University School of Medicine) St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center - Main Campus New York, United States
  • Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions